Transfusionsmedizin, Inhaltsverzeichnis Transfusionsmedizin 2015; 5(2): e1-e17DOI: 10.1055/s-0035-1546044 CME-Fortbildung Georg Thieme Verlag KG Stuttgart · New York Erythrozytentransfusion: prätransfusionelle Diagnostik – Teil 2 F. F. Wagner Artikel empfehlen Abstract Artikel einzeln kaufen Volltext Referenzen Literatur 1 Vorstand der Bundesärztekammer. Richtlinien zur Gewinnung von Blut und Blutbestandteilen und zur Anwendung von Blutprodukten (Hämotherapie). Zweite Richtlinienanpassung 2010 BAnz. Nr. 101a, Jahrgang 62. 2 Daniels G, Poole J, de Silva M et al. The clinical significance of blood group antibodies. Transfus Med 2002; 12: 287-295 3 Poole J, Daniels G. Blood group antibodies and their significance in transfusion medicine. Transfus Med Rev 2007; 21: 58-71 4 SWISSMEDIC. Transfusionsmedizinische Laboruntersuchungen an Patientenproben. Empfehlungen der SVTM und der B-CH SRK für Fachpersonen, Laboratorien und medizinische Institution zu immunhämatologischen und molekularen Untersuchungen an Patientenblutproben (01.01.2015). Im Internet: http://www.svtm-asmt.ch/upload/File/EMP001_Transfusionsmed_Laborunters_Pat%2520_D_V04.pdf Stand: 28.02.2015 5 Voak D. The status of new methods for the detection of red cell agglutination. Transfusion 1999; 39: 1037-1040 6 Weisbach V, Kohnhäuser T, Zimmermann R et al. Comparison of the performance of microtube column systems and solid-phase systems and the tube low-ionic-strength solution additive indirect antiglobulin test in the detection of red cell alloantibodies. Transfus Med 2006; 16: 276-284 7 Cid J, Nogués N, Montero R et al. Comparison of three microtube column agglutination systems for antibody screening: DG Gel, DiaMed-ID and Ortho BioVue. Transfus Med 2006; 16: 131-136 8 Winters JL, Richa EM, Bryant SC et al. Polyethylene glycol antiglobulin tube versus gel microcolumn: influence on the incidence of delayed hemolytic transfusion reactions and delayed serologic transfusion reactions. Transfusion 2010; 50: 1444-1452 9 CBO. Blood transfusion guideline. Im Internet: http://www.sanquin.nl/en/products-services/ Stand: 28.02.2015 10 Issitt PD, Combs MR, Bredehoeft SJ et al. Lack of clinical significance of “enzyme-only” red cell alloantibodies. Transfusion 1993; 33: 284-293 11 SHOT. SHOT-reports annual reports and summaries (2008–2013). Im Internet: http://www.shotuk.org/shot-reports/ Stand: 28.02.2015 12 Ministre délégué à la santé. Arrêté du 26 avril 2002: bonnes pratiques dʼimmuno-hʼemato. Im Internet: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000778935 Stand: 28.02.2015 13 Kanter MH, Poole G, Garratty G. Misinterpretation and misapplication of p values in antibody identification: the lack of value of a p value. Transfusion 1997; 37: 816-822 14 Seltsam A, Wagner F, Lambert M et al. Recombinant blood group proteins facilitate the detection of alloantibodies to high-prevalence antigens and reveal underlying antibodies: results of an international study. Transfusion 2014; 54: 1823-1830 15 Seltsam A, Agaylan A, Grueger D et al. Rapid detection of JMH antibodies with recombinant Sema7A (CD108) protein and the particle gel immunoassay. Transfusion 2008; 48: 1151-1155 16 Tait EJA, Fraser R, Moss M et al. Synthetic Peptide Mimotopes of blood Group Antigens for Red Cell Antibody Screening, ASH Meeting 2008 Abst 291 (26.10.2010). Im Internet: https://ash.confex.com/ash/2008/webprogram/Paper2186.html Stand: 10.02.2015 17 Heathcote D, Carroll T, Wang JJ et al. Novel antibody screening cells, MUT+Mur kodecytes, created by attaching peptides onto red blood cells. Transfusion 2010; 50: 635-641 18 Robb JS, Renault NK, Robson DC. Evaluation of a Novel Serology-Based Platform for Irregular Blood Group Antibody Identification (Project MosaiQ™) AABB Annual Meeting 2013. Im Internet: http://files.quotient-merged.gethifi.com/mosaiq/scientific-presentations/130699_ABS_Scientific_Poster_Antibody_304.8x304.8_HR.pdf Stand: 26.04.2015 19 Leger RM, Garratty G. Evaluation of methods for detecting alloantibodies underlying warm autoantibodies. Transfusion 1999; 39: 11-16 20 Young PP, Uzieblo A, Trulock E et al. Autoantibody formation after alloimmunization: are blood transfusions a risk factor for autoimmune hemolytic anemia?. Transfusion 2004; 44: 67-72 21 Ahrens N, Pruss A, Kähne A et al. Coexistence of autoantibodies and alloantibodies to red blood cells due to blood transfusion. Transfusion 2007; 47: 813-816 22 Engelfriet CP, Reesink HW, Garratty G et al. The detection of alloantibodies against red cells in patients with warm-type autoimmune haemolytic anaemia. Vox Sang 2000; 78: 200-207 23 Shirey RS, Boyd JS, Parwani AV et al. Prophylactic antigen-matched donor blood for patients with warm autoantibodies: an algorithm for transfusion management. Transfusion 2002; 42: 1435-1441 24 Roback JD, Grossman BJ, Harris T, Hillyer CD Hrsg. Technical Manual. 17. Aufl.. Bethesda: AABB; 2011 25 Judd WJ, Barnes BA, Steiner EA et al. The evaluation of a positive direct antiglobulin test (autocontrol) in pretransfusion testing revisited. Transfusion 1986; 26: 220-224 26 Stec N, Shirey RS, Smith B et al. The efficacy of performing red cell elution studies in the pretransfusion testing of patients with positive direct antiglobulin tests. Transfusion 1986; 26: 225-226 27 Domen RE, Grattan J. Efficacy of performing red-cell antibody elutions in patients with a positive direct antiglobulin test. Vox Sang 1986; 51: 324-326 28 López J, Fernández Villalta MJ, de la Calle C et al. [Critical analysis of the routine use of the direct antiglobulin test in 22,517 cross-matching tests]. Sangre (Barc) 1990; 35: 15-17 29 Richa E, Benidt G, Tauscher C et al. Eluate testing following microscopically positive direct antiglobulin tests with anti-IgG. Ann Clin Lab Sci 2007; 37: 167-169 30 Yazer MH, Triulzi DJ. The role of the elution in antibody investigations. Transfusion 2009; 49: 2395-2399 31 Nathalang O, Sriwanitchrak P, Tubrod J et al. Antibody elutions in Thai patients with a positive direct antiglobulin test. Blood Transfus 2011; 9: 306-310 32 Österreichische Gesellschaft für Blutgruppenserologie und Transfusionsmedizin, Direktorium für das Blutspendewesen des Österreichischen Roten Kreuzes. Richtlinien in der Blutgruppenserologie und Transfusionsmedizin betreffend die Bereiche Transfusion von Blut- und Blutkomponenten und Blutgruppenserologische Untersuchungen (07.2000). Im Internet: http://www.oegbt.at/wp-content/static/Richtlinien_Empfehlungen/Richtlinien_in_der_Blutgruppenserologie_und_Transfusionsmedizin_Teil4.2000.pdf Stand: 28.02.2015 33 Lange J, Selleng K, Heddle NM et al. Coombsʼ crossmatch after negative antibody screening–a retrospective observational study comparing the tube test and the microcolumn technology. Vox Sang 2010; 98 (3 Pt 1) e269-e275 34 TRIP foundation. TRIP annual report 2009–2012 Hemovigilance. Im Internet: https://www.tripnet.nl/pages/en/publicaties.php Stand: 28.02.2015 35 Schonewille H, van Zijl AM, Wijermans PW. The importance of antibodies againstlow-incidence RBC antigens in complete and abbreviated cross-matching. Transfusion 2003; 43: 939-944 36 Ministre délégué à la santé. Arrêté du 26 avril 2002: bonnes pratiques dʼimmuno-hʼemato. Im Internet: http://www.legifrance.gouv.fr/affichTexte.do?cidTexte=JORFTEXT000000778935 Stand: 28.02.2015 37 Bundesärztekammer. Richtlinie der Bundesärztekammer zur Qualitätssicherung laboratoriumsmedizinischer Untersuchungen. Deutsches Ärzteblatt 2014; 111: 1583-1618 38 Wagner FF. Why do we use serological blood group phenotype determination in chronically transfused patients?. Blood Transfus 2014; 12: 1-2 39 Tormey CA, Fisk J, Stack G. Red blood cell alloantibody frequency, specificity, and properties in a population of male military veterans. Transfusion 2008; 48: 2069-2076 40 Hoeltge GA, Domen RE, Rybicki LA et al. Multiple red cell transfusions and alloimmunization. Experience with 6996 antibodies detected in a total of 159,262 patients from 1985 to 1993. Arch Pathol Lab Med 1995; 119: 42-45 41 Saverimuttu J, Greenfield T, Rotenko I et al. Implications for urgent transfusion of uncrossmatched blood in the emergency department: The prevalence of clinically significant red cell antibodies within different patient groups. Emerg Med (Fremantle) 2003; 15: 239-243 42 Domen RE, Ramirez G. Red cell alloimmunization in chronic renal failure patients undergoing hemodialysis. Nephron 1988; 48: 284-285 43 Stiegler G, Sperr W, Lorber C et al. Red cell antibodies in frequently transfused patients with myelodysplastic syndrome. Ann Hematol 2001; 80: 330-333 44 Sanz C, Nomdedeu M, Belkaid M et al. Red blood cell alloimmunization in transfused patients with myelodysplastic syndrome or chronic myelomonocytic leukemia. Transfusion 2013; 53: 710-715 45 Matteocci A, Pierelli L. Red blood cell alloimmunization in sickle cell disease and in thalassaemia: current status, future perspectives and potential role of molecular typing. Vox Sang 2014; 106: 197-208 46 Chou ST, Liem RI, Thompson AA. Challenges of alloimmunization in patients with haemoglobinopathies. Br J Haematol 2012; 159: 394-404
